Comments
Loading...
FibroGen (FGEN) Forecast
NewsEarningsFibroGen (FGEN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestFibroGen (NASDAQ:FGEN) Stock Quotes, Forecast and News Summary
FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy FibroGen (FGEN) stock?
You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.
Who are FibroGen (FGEN) competitors?
Other companies in FibroGen’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), OncoCyte (NASDAQ:OCX), Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR) and Aligos Therapeutics (NASDAQ:ALGS).
What is the forecast, or price target, for FibroGen (FGEN) stock?
FibroGen has a consensus price target of $10.00.
What is the current price for FibroGen (FGEN)?
The stock price for FibroGen (NASDAQ: FGEN) is $0.724 last updated February 21, 2025 at 10:42 AM EST.
Does FibroGen (FGEN) pay a dividend?
There are no upcoming dividends for FibroGen.
When is FibroGen (NASDAQ:FGEN) reporting earnings?
FibroGen’s Q1 earnings are confirmed for Monday, May 5, 2025.
Is FibroGen (FGEN) going to split?
There is no upcoming split for FibroGen.
What sector and industry does FibroGen (FGEN) operate in?
FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.